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GUIDELINES

Guidelines for the Initial Management of Adults with Sepsis/Severe Sepsis/Septic Shock: 2015
Erfan Hussain*, Bushra Jamil**, Naseem Salahuddin***
*Section of Pulmonary and Critical Care Medicine, Department of Medicine, **Adult Infectious Diseases,
The Aga Khan University, Karachi, Pakistan.
*** Indus Hospital, Karachi, Pakistan
The “3 Hour” Bundle
Introduction
Sepsis is the leading cause of morbidity and mortality. It is
estimated that 60-80% of deaths in low and in low to middle
income countries occurs due to sepsis.1,2 Data from Pakistan
is scanty. Sepsis accounts for about 1.3% of all admissions at
the Aga Khan University Hospital, Karachi, Pakistan, and has
mortality approaching 37%, which is significantly associated
with the presence of septic shock.3
With the publication of both the Protocol Based Care for Early
Septic Shock (ProCESS) and the Australasian Resuscitation in
Sepsis Evaluation (ARISE) trials in 2014, the importance of
adherence to the 3 Hour Bundle of initial sepsis management
to significantly impact on the morbidity and mortality of patients
along the sepsis spectrum, was recognized.4,5,6
Severe sepsis and septic shock can be managed effectively
using our locally-adapted sepsis guidelines, which delineate
simple interventions to be instituted in a timely manner. This
is expected to have a significant impact on sepsis outcomes in
our patients.
The 3 Hour Bundle Management Protocol (Appendix 1)
There are 4 main components to the 3 Hour Bundle. These are:
1.
2.
3.
4.

Early recognition of Sepsis/Severe Sepsis/Septic Shock
Diagnostic work up
Antibiotic administration
Fluid and vasopressor management

Early Recognition
Early recognition of the patient presenting along the sepsis
spectrum remains critical to the effective early implementation
of the 3 Hour Bundle. Two main areas to the successful
development of early recognition are education and the use of
screening tools.
1. Education
Education remains a cornerstone in the successful
implementation of guidelines into practice. It is hoped that with
the development and acceptance of these guidelines a local,
provincial and national dialogue can be started as to how to
collect the necessary epidemiological data for sepsis as well as
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as well as plan for dissemination of these guidelines to the
healthcare professionals and our patients
2. Screening Tools
The use of a screening tool can both help educate and provide
rapid identification of the patient with sepsis by first responders
such as: ER Triage nurses and physicians, Rapid Response and
Cardiac Arrest Teams, and the bedside and/or OPD nurse and
physician. An example of a sepsis screening tool is provided
in Appendix 2.
Diagnostic Work Up
When possible a complete diagnostic panel for patients with
sepsis should be sent including:
Complete blood count and Platelets
Basic Electrolytes (Sodium, Potassium, Chloride,
Bicarbonate, Glucose, Bun and Creatinine)
PT/PTT and INR
Urine DR
Cultures: Blood, Urine and Sputum
Lactic Acid
Radiological studies (x-rays, ultrasound, CT scans) should be
ordered guided by the history and physical exam. If an infective
source is identified that is amenable to surgical correction a
surgical consult should be called early for appropriate source
control.
Special Consideration of the following is recommended:
Blood Cultures. Please see Appendix 3 for proper sampling
and handling of blood cultures
Biomarkers of Sepsis: Biomarkers of sepsis such as ESR
and CRP have no role in the diagnosis, prognostication
and/or therapy guidance of sepsis. At present only
Procalcitonin has any significant sensitivity and specificity
for diagnosis, prognostication and therapy guidance for
sepsis. Having said that the sensitivity and specificity for
any of the above tests (including Procalcitonin) remains
less than optimal and therefore its routine use in sepsis
cannot be recommended.7,8
Lactate: The last decade has seen resurgence in the
diagnostic, prognostic and therapeutic guidance of lactate
for the patient with sepsis, severe sepsis septic shock.9,10,11,12
It is important to emphasize that the patient who meets the

o

o
o

definition of sepsis and yet has no other signs, symptoms
or laboratory evidence suggestive of severe sepsis can still
meet the new operational definition of severe sepsis with
an isolated lactate of 4 mmol/L or higher (Glossary of
Terms).
Base Deficit: In view of the resource limitations to
healthcare delivery in Pakistan it is understood that a blood
lactate test may not be available. It is therefore suggested
that the base deficit in an arterial blood gas sample may be
used to detect acidosis in the patient with sepsis.13, 14 This
recommendation is made with the following caveats:

Please see Appendix 5 for details.

To date there has been no study to evaluate the utility of
base deficit in lieu of a serum lactate for the diagnosis of
severe sepsis or as a marker for resuscitation in severe
sepsis/septic shock.
Base deficit cannot be used as a surrogate marker for lactate
if there is hyperchloremic acidosis from normal saline
administration, renal failure or diabetic ketoacidosis.
Given the varied reasons for an elevated base deficit, it is
has limitations as an endpoint of resuscitation for sepsis.

Pedal peripheral IV access (foot IVs) should be avoided because
of the increase in transit time from the foot to the central
circulation that can result from vasoconstriction from hypotension,
shock, and/ or the administration of vasopressors.20, 21

Antibiotics
The importance of early and appropriate antibiotic administration
cannot be overemphasized in in managing sepsis. The study by
Kumar et al demonstrated that for every hour delay in
administration of antibiotics to the patient with sepsis induced
hypotension or shock resulted in 12% decreased probability of
survival.15
The factors which are clearly associated with sepsis outcomes
include the site of infection, the kind of organisms involved
and their susceptibility patterns, time to diagnosis and institution
of fluid resuscitation and the types of antibiotics selected for
empiric and definitive treatment.
Our local data shows that among enterobacteriaceae (E.coli,
klebsiella, enterobacter) resistance patterns are as follows:
3rd generation cephalosporins currently ranges from 50-80%,
ciprofloxacin 30-70%, piperacillin-tazobactam 20-30% and
carbapenems between 2-15% .16
Of special consideration is the fact that carbapenem resistance
enterobacteriaceae (CRE) is associated with a high sepsisrelated mortality of up to 80%.17 The numbers of deaths are 2fold higher among patients with bacteremia caused by CRE as
compared with carbapenem-sensitive enterobacteriaceae (CSE).18
In our context, mortality secondary to bacteremia caused by
carbapenem- resistant gram negatives (including
CRE,acinetobacter and pseudomonas) has been 54% vs 36%
due to sensitive organisms. With additional resistance to 3rd
generation cephalosporins and ciprofloxacin the mortality
approaches 90% .19
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Intravenous Fluids and Vasopressors:
Intravenous Access:
The following is suggested:
o Initial IV access for sepsis should be an upper extremity
peripheral line
o Initial IV access for severe sepsis and septic shock should
be either single or two upper extremity peripheral lines of
18 gauge or larger when possible.

o
o

o
o

o

o

Type of fluid for resuscitation:
For sepsis there is no recommendation for routine fluid
administration.
For severe sepsis and septic shock crystalloids (Normal
saline or Ringers Lactate) are recommended over colloids.9, 22
Dose and method of fluid administration for severe sepsis
and septic shock.10, 23, 24
In the 3 Hour bundle fluid is administered to a total dose
of 30cc/kg.
Crystalloid is administered as a fluid bolus
250 cc over 10 minutes
500 cc over 15 minutes
1000 cc over 30 minutes
Administer as follows:
10 ml/kg over 15-30 minutes
If a systolic blood pressure of 90mmHg or greater or a
Mean Arterial Pressure of 65 mmHg or greater is not
reached after the above bolus then repeat 5ml/kg over 15
minutes and repeat every 15 minutes until the above blood
pressure goal is reached or a total of 30 cc/kg administered.
Vasopressors
If vasopressors are used to support the blood pressure while
the fluid boluses are given or after the 30ml/kg total dose
is given and the patient is still in shock the following is
recommended.9, 25
Norepinephrine is the first line vasopressor for use in septic
shock
Dopamine may be used in place of Norepinephrine if
Norepinephrine is not available
If the maximum dose of Norepinephrine or Dopamine is
reached, and the patient is still in shock, then Epinephrine
can be added.
Vasopressin in doses of 0.03-0.04 units/min can be added
to norepinephrine to help attain the above blood pressure
Jan - Mar 2015. 785

targets or to reduce the dose of norepinephrine being given.
Recommendations for implementation and monitoring of
the 3 Hour Bundle
Order sets provide a method of funneling the decision
matrix of the bedside provider along best practice
recommendations.26 An example of an order set modified
and developed at the Aga Khan University Hospital (AKUH)
Karachi Pakistan is presented in the appendix section of
this document (Appendix 4). The addition of a carbon back
to the order set allows easy storage and later abstraction
of data for monitoring of compliance with the bundle
elements.
When following compliance of the 3 hour bundle in an
emergency room, time zero is when the patient presents to
triage.
An algorithm for the 3 hour bundle, modified and developed
at the AKUH Karachi Pakistan is presented in Appendix 1.
Following an institution’s lactate test volume and volume
of norepinephrine units used can help an organization
follow the penetration of the sepsis bundle in that
institution.12

c. Resp rate >20 breaths/min
d. WBC >12,000 or <4,000 or 10% bands
3. Sepsis28
SIRS + Infection (known or suspected source) = Sepsis
4. Severe Sepsis28
Sepsis criteria + evidence of organ dysfunction or Sepsis
criteria + Lactate >/ 4mmol/L
Cardiovascular: Systolic BP ≤90 mmHg, MAP ≤70 mm
Hg for at least 1 hour despite volume resuscitation, or the
use of vasopressors.
Renal: Urine output < 0.5 ml/kg body weight/hr for 1 hour
despite volume resuscitation. Creatinine > 2.0 mg/dL
Pulmonary: PaO2/FiO2 ≤250 if other organ dysfunction
present or ≤ 200 if the lung is the only dysfunctional organ.
Hematologic: Platelet count ≤100K or decreased by 50%
in 3 days
Metabolic: pH ≤ 7.3 and plasma lactate > 4
Altered Mental Status
Bilirubin > 2mg/dL

Glossary of Terms:

5. Septic Shock10
Persistent arterial hypotension despite adequate volume
resuscitation

1. Bundle:
A set of evidence based diagnostic and therapeutic interventions
(usually 3-5 elements) that together can help improve patient
outcomes.27

6. Hypotension10
Systolic blood pressure of <90 mmHg, or a mean arterial
pressure (MAP) < 65 mmHg, or a decrease of >/ 40mmHg in
the systolic blood pressure from baseline

2. Systemic Inflammatory response (SIRS)28 2 or more of
the following:
a. Temp>38 or <36
b. Heart rate >90 beats/min

7. Shock10
Life threatening, generalized form of circulatory failure
associated with inadequate oxygen utilization by the cells
resulting in cellular dysoxia
( See appendex 1 to 5 from next page.)
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Appendix 1
SIRS criteria
•
Temp>38°C or <36°C
•
Heart rate >90 beats/min
•
Resp rate >20 breaths/min
•
WBC >12,000 or <4,000 or 10% bands
SIRS + Infection = SEPSIS
SEVERE SEPSIS
Sepsis criteria + evidence of organ dysfunction or Sepsis criteria + Lactate 4mmol/L
•
•
•
•
•
•

CV: Systolic BP ≤90 mmHg, MAP ≤70 mm Hg for at least 1 hour despite volume resuscitation,
or the use of vasopressors.
Renal: Urine output < 0.5 ml/kg body weight/hr for 1 hour despite volume resuscitation
Pulmonary: PaO2/FiO2 ≤250 if other organ dysfunction present or ≤200 if the lung is the only dysfunctional organ.
Hematologic: Platelet count ≤100K or decreased by 50% in 3days
Metabolic: pH ≤7.3 and plasma lactate > 4 mmol/L
Altered Mental Status
Recognize Severe Sepsis. FILL OUT SEPSIS ORDER SET

Cultures + Lactate, CBC, Basic Metabolic panel PT/PTT INR, LFTs, Urine DR
Radiology: CxR and others
Early Surgical Consultation is recommended if the above work up suggests a surgical amenable focus of infection

Start Antibiotics (Refer to Hospital Antibiogram)

If MAP <65 mmHg and/or Lactate > 4mmol/L and/or signs/labs of organ dysfunction START IVF Crystalloid
(10 ml/kg) over 15-30 minutes THEN If BP goal not attained give 5ml/kg every 15 minutes up to 30 ml/kg

PATIENT REMAINS WITH MAP < 65 mmHg AFTER I L of FLUID START
NOREPINEPHRINE AT 0.01 µg/kg/min and titrate to MAP 65 mmHg. CONTINUE FLUID RESUSCITATION
UNTIL TOTAL 30cc/kg/ given

Insert Central Venous Access at 3 hours if patient still in shock and titrate Norepinephrine to obtain a MAP >/ 65 mmHg.
IF PATIENT IN SHOCK AFTER 3 HOURS OR REPEAT LACTATE 4 mmol/L at 3 HOURS THEN:

ADVANCE RESUSCITATION : CALL EXPERT CONSULTATION
Volume 24 Issue 01
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Appendix 2
Evaluation for Severe Sepsis Screening Tool
Instructions: Use this optional tool to screen patients for severe sepsis in the emergency department, on the
medical/surgical floors, or in the ICU.
1. Is the patient’s history suggestive of a new infection?
Pneumonia, empyema
Urinary tract infection
Acute abdominal infection
Meningitis
Skin/soft tissue infection

Bone/joint infection
Wound infection
Blood stream catheter infection
Endocarditis

Implantable device infection
Other infection

Yes

No

2. Are any two of following signs & symptoms of infection both present and new to the patient? Note: laboratory
values may have been obtained for inpatients but may not be available for outpatients.
Hyperthermia > 38.3 °C (101.0 °F)
Hypothermia < 36 °C (96.8°F)
Altered mental status
Tachycardia > 90 bpm

Tachypnea > 20 bpm
Leukocytosis (WBC count >12,000 µL–1)
Leukopenia (WBC count < 4000 µL–1)

Hyperglycemia (plasma glucose
>140 mg/dL) or 7.7 mmol/L in
the absence of diabetes

If the answer is yes, to both questions 1 and 2, suspicion of infection is present:
Obtain: lactic acid, blood cultures, CBC with differential, basic chemistry labs, bilirubin.
At the physician’s discretion obtain: UA, chest x-ray, amylase, lipase, ABG, CT scan.
Yes

No

3. Are any of the following organ dysfunction criteria present at a site remote from the site of the infection that are
NOT considered to be chronic conditions? Note: in the case of bilateral pulmonary infiltrates the remote site stipulation
is waived.
SBP < 90 mmHg or MAP <65 mmHg
SBP decrease > 40 mm Hg from baseline
Creatinine > 2.0 mg/dl (176.8 mmol/L) or urine output < 0.5 ml/kg/hour for 2 hours Bilirubin > 2 mg/dl (34.2 mmol/L)
Platelet count < 100,000 µL Lactate > 2 mmol/L (18.0 mg/dl)
Coagulopathy (INR >1.5 or aPTT >60 secs)
Acute lung injury with PaO2/FiO2 <250 in the absence of pneumonia as infection source
Acute lung injury with PaO2/FiO2 <200 in the presence of pneumonia as infection source
Yes
No
If suspicion of infection is present AND organ dysfunction is present, the patient meets the criteria for SEVERE
SEPSIS and should be entered into the severe sepsis protocol.

Date:
_/
Version 7.2.13

/

(circle: dd/mm/yy or mm/dd/yy)
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Time:

_:

(24 hr. clock)

Appendix 3
Technique for Proper Blood Culture Sampling
1.

Gather necessary equipment: 20 ml syringe, 2 aerobic
and 2 anaerobic bottles for 2 sets of blood cultures, skin
prep swabs, tourniquet, sharps disposal box, gloves.

2.
3.

4.
5.

2.

Verify the patient's identification and explain procedure

3.

Wash or sanitize hands before and after removing gloves.
Follow Standard Precautions for all patients. Wear clean
gloves.

If unable to use either of the above
a) Use alcohol to cleanse the patient's skin, using a
circular motion starting at the site and moving
outward.
b) Repeat times two.
c) Allow to dry.
6. Do not touch the venipuncture site after skin
preparation. If palpation is absolutely necessary,
sterile gloves must be applied immediately prior to
palpation.
7. Insert needle into vein and withdraw 20 ml of blood.
Do not collect blood through IV cannula even it is
freshly inserted.

Masks with face shields may be worn for drawing blood
cultures depending on the clinical situation.
4.

5.

Assemble necessary equipment before preparation of the
patient's skin.
1. Remove dust caps from culture bottles.
2. Clean surface with alcohol wipe.
3. Leave the alcohol wipe on the bottle top during skin
preparation.
Remove alcohol wipe just prior to inoculating the bottles
- do not use iodine.

6.

Apply tourniquet to the extremity and identify the
phlebotomy site.

7.

Preparation of the phlebotomy site: clean site with
chloraprep or 70% isopropyl alcohol for 30 seconds
prior to chlorhexidene or povidone iodine (if chorhexidene
is not available,inferior)

1. Using chloraprep, use a firm scrubbing motion for

30 seconds over a 5 cm area of the skin using circular
motion starting at the site and working outward.
Allow 30 seconds for drying before venipuncture.
Using sequential chlorhexidene or povidone iodine,
cleanse a 5 cm area using circular motion starting
at the site and working outward.
Allow to dry for a at least 30 seconds to allow
antiseptic effect
Clean patient's skin with alcohol to remove excess
iodine (to prevent iodine burns).

8.

Inject 10 ml of blood into each culture bottle. Needles
should not be changed before inoculating culture medium.

9.

If an inadequate amount of blood was obtained (less
than 5 ml), and repeat phlebotomy cannot be performed;
all blood should be preferentially inoculated in the
aerobic culture bottle.

10. Label culture bottles with patient's name and MR number.
11. Fill out Microbiology lab slip.
1. Indicate site from which blood was collected using
comment section. If using aVascular Access Device
(VAD) to draw culture, you must indicate type and
site of VAD in the comments section (i.e., left
subclavian triple lumen).
2. Indicate suspected diagnosis, if necessary (required
for R/O endocarditis).
3. Include date and time of collection.
4. Document that cultures were obtained on appropriate
form
12. Send specimens to the laboratory as soon as possible.
Do not refrigerate blood culture specimens.
Contd. on next page
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13. Send second set of blood cultures using the same
procedure as above. If a different peripheral site is
possible, the second set may be drawn immediately. If
using the same site, wait at least 10 minutes for the
second set, and if possible (i.e. not waiting to give
antibiotics) draw second set 1-3 hours later.
Biosafety Considerations:
Discard used syringes in the sharps bin; used gloves and
swabs should be discarded as controlled medical waste.
14. In order to rule out diagnoses, more specific blood
culture procedures may be necessary.
1. Suspected catheter sepsis
1. Draw two culture sets, using a fresh syringe
for every venipuncture/draw
2. One set is obtained from a suspected site.
3. Second set must be from a separate peripheral site.
4. If catheter is removed, send tip (3 cm) using
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sterile procedure for cultures. Do not send
catheter tipwithout sending concomitant
blood cultures.
2. Acute endocarditis
1. Draw two culture sets from two separate sites
during the first 1-2 hours of evaluation.
2. Begin therapy.
3. Subacute endocarditis
1. Draw 2-3 blood culture sets on day 1.
2. If all are negative additional sets can be drawn
on days 2 and 3 (no more than 4 sets in a 24
hour period).
3. Immediate antibiotics are less important than
establishing a specific microbial diagnosis.
4. Endocarditis patients on anti-microbial therapy
1. Draw resin blood culture sets on each of three
successive days.
2. Indicate "R/O endocarditis" in special
instructions on lab requisition.

Appendix 4
PHYSICIANS’ ORDERS

Patient Identification & Location

ADULT SEPSIS ORDER SET PAGE 1 of 3
Note:

Check Box Where Appropriate

PLEASE WRITE ALL ‘MEDICATION AND IV FLUID’ ORDERS ON THE SEPARATE SHEET,
DESIGNED FOR THE PURPOSE
DATE AND TIME

ORDER, SIGNATURE AND TITLE
Allergies:
Attending Physician:
Primary Diagnosis:
Sepsis

Severe Sepsis

RN SIGNATURE - TIME

Septic Shock

Secondary Diagnosis:

Pneumonia
Abd Infection

Urinary Tract Infection
Other

Condition:

Critical

Stable

Admit to:
Oxygen:
Vital Signs every 15 minutes X 1 hour, then per unit policy
Strict Intake and Output
Activity:
Bed Rest
Other
Diet:
NPO
Other
LABS:
Sepsis Panel (IF CHECKED SEND ENTIRE LABS BELOW)
: CBC with Differential and Platelet Count
: PT/PTT
: BUN/Creatinine
: Serum Electrolytes (Na, K, Cl, HCO3, BUN, Creatinine)
: Lactic Acid and Repeat every 6 hours for next 24 Hours
: Urine DR
: Procalcitonin
: Blood Cultures X2
: Urine Cultures
: Sputum Cultures
: Cultures Other
Additional Labs:

Chest X-Ray
Other Imaging Studies

EKG 12 Lead
IV Saline Lock with flush of Normal Saline 3ml every 12 hours
Volume 24 Issue 01

Jan - Mar 2015. 791

PHYSICIANS’ ORDERS

Patient Identification & Location

ADULT SEPSIS ORDER SET PAGE 2 of 3
Note:

Check Box Where Appropriate

PLEASE WRITE ALL ‘MEDICATION AND IV FLUID’ ORDERS ON THE SEPARATE SHEET,
DESIGNED FOR THE PURPOSE

DATE AND TIME

ORDER, SIGNATURE AND TITLE
DVT Prophylaxsis:
ANTIBIOTICS: ADJUST FOR RENAL and/or HEPATIC DYSFUNCTION

SEPSIS SOURCE UNKNOWN:
Piperacillin-Tazobactum
OR
Imipenem Cilastatin
OR
Cefoperazone Sulbactam
And Clindamycin
IF MRSA SUSPECTED THEN ADD

3.375gm Q6 Hours IV
500mg Q8 Hours IV
400mg Q12 Hours IV
600mg Q8 Hours IV

Vancomycin: Load
20mg/kg IV
Maintenance 15mg/kg Q 12 Hours IV
SUSPECTED
Piperacillin-Tazobactum
And Levofloxacin
OR
Ceftriaxone
And Levofloxacin

3.375gm Q6 Hours IV
500mgQ24 Hours IV
2gm Q24 Hours IV
500mg Q24 Hours IV

SUSPECTED SKIN & SOFT TISSUE INFECTION:
Cefazolin
2gm Q8 Hours IV
IF Penicillin Allergic
Clindamycin
600mg Q8 Hours IV
And
Ciprofloxacin
400mg Q12 Hours IV
IF MRSA SUSPECTED THEN ADD
Vancomycin: Load
20mg/kg IV
Maintenance 15mg/kg Q 12 Hours IV
SUSPECTED ABDOMINAL INFECTION:
Piperacillin-Tazobactum
3.375gm Q6 Hours IV
OR
Imipenem Cilastatin
1 gm Q8 Hours IV
OR
Ceftriaxone
2gm Q24 Hours IV
And Amikacin
15mg/kg Q24 Hours IV
And Metronidazole
500mg Q8 Hours IV

792 . Infectious Diseases Journal of Pakistan

RN SIGNATURE - TIME

PHYSICIANS’ ORDERS

Patient Identification & Location

ADULT SEPSIS ORDER SET PAGE 3 of 3
Note:

Check Box Where Appropriate

PLEASE WRITE ALL ‘MEDICATION AND IV FLUID’ ORDERS ON THE SEPARATE SHEET,
DESIGNED FOR THE PURPOSE

DATE AND TIME

ORDER, SIGNATURE AND TITLE
SUSPECTED UROSEPSIS
Piperacillin-Tazobactum
OR
Imipenem Cilastatin
IF RISK OF ENTEROCCOCUS
Vancomycin: Load
Maintenance
SUSPECTED CNS INFECTION
Ceftriaxone
AND
Vancomycin: Load
Maintenance
OR
Meropenem

RN SIGNATURE - TIME

3.375gm Q6 Hours IV
500mg Q8 Hours IV
20mg/kg IV
15mg/kg Q 12 Hours IV

2gm Q24 Hours IV
20mg/kg IV
15mg/kg Q 12 Hours IV
2gm Q8 Hours IV

SUSPECTED HOSPITAL ACQUIRED INFECTION
Piperacillin-Tazobactum
3.375gm Q6 Hours IV
AND Vancomycin: Load
20mg/kg IV
Maintenance
15mg/kg Q 12 Hours IV
OR
Imipenem Cilastatin
500mg Q8 Hours IV
AND Vancomycin: Load
20mg/kg IV
Maintenance
15mg/kg Q 12 Hours IV
AND
Colistin 9MU stat and 3MU Q 8hours IV
See appendix 5 for details
FOR PATIENTS WITH SYSTOLIC BLOOD PRESSURE LESS THAN 90 mmHg

Initial intravenous fluids per kg estimated ideal body weight
Target BP greater than 90 mmHg systolic and Mean Arterial Pressure
(MAP) greater than 65 mmHg
Normal saline (10 ml/kg)
ml over 15-30 minutes THEN
If BP goal not attained 5ml/kg every 15 minutes up to 30 ml/kg
Ringers Lactate (10 ml/kg)
ml over 13-30 minutes THEN
If BP goal not attained 5ml/kg every 15 minutes up to 30 ml/kg
VASOPRESSOR (Titrate to systolic BP greater than 90 mmHg and
MAP greater than 65 mmHg
Norepinephrine
mg in
ml D5W at
micrograms/min
Continuous Infusion
IF AFTER RECEIVING FLUID BOLUS 30ml/kg PATIENT STILL
IN SHOCK AND/OR REPEAT LACTATE 4 OR GREATER OBTAIN
URGENT EXPERT CONSULTATION
Volume 24 Issue 01
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Appendix 5

Antibiotics in Sepsis

Before Selecting Empirical therapy
•
•
•
•
•
•
•
•
•

Selection of antibiotic must be based on clinical assessment of site of infection
Viremia, severe malaria or fungemia must be considered as possible causes of sepsis
Antibiotics must be administered as soon as possible, within 2 hours of admission to ER or ICU
Two sets of blood cultures, urine analysis and urine culture must be drawn prior to institution of antibiotic
Obtain history of previous use of antibiotics in past 3 months. Avoid same antibiotic if possible
Dose must be prescribed on weight basis
Dose must be adjusted for renal or hepatic insufficiency, diabetes
Hematologic malignancy or febrile neutropenia must be considered
Combination therapy and use of colistin may be considered for suspected highly resistant pathogens, e.g sepsis
in patients with pro-longed hospital or ICU stay, transfer from another healthcare facility, immunocompromised status.
Only intravenous antibiotic should be used until there is clinical improvement
Empiric antifungal therapy may be considered initially in specific circumstances, e.g. perforated viscus or prolonged
antibacterial therapy in immunocompromised patients

•
•

During antibiotic therapy
•
•

Once culture and sensitivity reports are available, de-escalate to a narrower spectrum antibiotic
Once patient shows clinical improvement and is stable, de-escalate to oral preparation, if an equally effective oral
preparation is available
Antibiotic should be given for no longer than 7-10 days
Source control is essential, i.e. drainage of abscess, repair or resection of perforated viscus, removal of cannula, catheter,
devices, debridement of infected tissue.

•
•
Table 1

Source of infection

Likely pathogen

Urinary tract

E. coli

Genital tract
Respiratory tract (CAP)
Respiratory tract (HAP)

E. coli, Enterococcus, S hemolyticus,
Anaerobes
S. pneumoniae, atypical
GPC, GNR, atypical

Respiratory tract (VAP)

GNR, MRSA

Intra-abdominal

Gram negatives, anerobes

SSTI (necrotizing fasciitis)

S. aureus, Streptococci anerobes

Burn sepsis

S. aureus, Streptococci, Pseudomonas,
Candida
S. aureus, (MSSA, MRSA), Pseudomonas
S. aureus, (MSSA, MRSA), Pseudomonas
S pneumoniae, Meningococcus

Line sepsis
Infected device
Bacterial meningitis
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Best empirical antibiotic
Carbapenem or Piperacillin –tazobactam or
Cefaperazone-sulbactam
Carbapenem or Piperacillin –tazobactam or
Cefaperazone-sulbactam + vancomycin
Ceftriaxone +levofloxacin or clarithromycin
Carbapenem or Piperacillin –tazobactam or
Cefaperazone-sulbactam + levofloxacin or
clarithromycin
Carbapenem or Piperacillin –tazobactam
+ Colistin (colistimethate sodium)9MU stat and
3MU Q 8hours IV or
Cefaperazone-sulbactam + vancomycin+ Colistin
9MU stat and 3MU Q 8hours IV
Carbapenem or Piperacillin –tazobactam or
Cefaperazone-sulbactam + vancomycin
Amoxicilin/clavulanate or clindamycin
+vancomycin
Carbapenem or Piperacillin –tazobactam or
Cefaperazone-sulbactam + vancomycin
Ceftazidime or amikacin+ vancomycin
Ceftazidime or amikacin+ vancomycin
Ceftriaxone + vancomycin + steroid

Table 2
Class

Spectrum

Route of

Effective against
administration

Carbapenem

Broad

Meroponem/imepenem
/ ertapenem

Intravenous

GPC, GNB,
anaerobes

B lactamase
inhibitor
3rd gen
Cephalosporin

Broad

Piperacillin – tazobactam Intravenous

GPC, GNB,
anaerobes.

Broad

Cefaperazone- sulbactam Intravenous

GPC, GNB,
anaerobes.

MRSA, VRE

Cefazolin, Cephradine

Intravenous

Strept

MRSA,VRE,anaerobes

Ceftriaxone

Intravenous

Strept, GNR

MRSA,VRE,anaerobes

Ceftazidime
Vancomycin
Amikacin, Tobramycin,
Gentamicin

Intravenous
Intravenous
Intravenous

GNR, esp pseudom MRSA,VRE,anaerobes
MRSA,enterococcus GNR, anaerobes
GNRStrept and Entero,, anaerobes

1st gen
cephalosporin Narrow
3rd gen
Cephalosporin Broad
3rd gen
Cephalospor
Broad
Glycopeptide Narrow
Aminoglycoside Narrow
B lactamase
inhibitor

Broad

FluoroquinolonesBroad
Macrolides

Narrow

Lincosamide

Narrow

Available preparations

Amoxicillin- clavulanate Intravenous
and oral
Levofloxacin
Intravenous
and oral
Azithromycin,
Oral
clarithromycin
Clindamycin
Intravenous
and oral

GPC= gram positive cocci, GNR= gram negative rods
MSSA= methicillin sensitive Staph aureus
MRSA= methicillin resistant Staph aureus
Submitted by : Dr. Naseem Salahuddin
Endorsed by : Members of Medical Microbiologists and
Infectious Disease Society of Pakistan
(MMIDSP)
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